Should very low doses of hydroxychloroquine and quinacrine be employed in combination for long-term maintenance of remission in systemic lupus to reduce the risk of ocular toxicity?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current opinion in rheumatology 2015-05, Vol.27 (3), p.213-215
Hauptverfasser:	McCune, W Joseph, Gonzalez-Rivera, Tania
Format:	Artikel
Sprache:	eng
Schlagworte:	Antimalarials - administration & dosage Dose-Response Relationship, Drug Drug Therapy, Combination Eye Diseases - chemically induced Eye Diseases - prevention & control Follow-Up Studies Humans Hydroxychloroquine - administration & dosage Lupus Erythematosus, Systemic - drug therapy Quinacrine - administration & dosage Remission Induction Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!